Brainsway (BWAY) Liabilities and Shareholders Equity (2018 - 2025)
Brainsway (BWAY) reported Liabilities and Shareholders Equity of $113.2 million for Q4 2025, up 20.01% on a YoY basis from $94.3 million in Q4 2024, and up 1.46% quarter-over-quarter from $111.6 million in Q2 2025.
Brainsway (BWAY) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends
Brainsway has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $113.2 million in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 20.01% year-over-year to $113.2 million; the trailing twelve-month figure through Mar 2026 stood at $224.8 million (up 138.3% YoY), and the FY2025 full-year result was $113.2 million, up 20.01% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $113.2 million, up from $111.6 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $113.2 million in Q4 2025, with the low at $63.0 million in Q4 2023.
- Historically, Liabilities and Shareholders Equity has averaged $83.0 million across 5 years, with a median of $75.7 million in 2021.
- Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity soared 122.67% — and 2022, when it retreated 14.86%.
- Brainsway's Liabilities and Shareholders Equity stood at $75.7 million in 2021, then dropped by 14.86% to $64.5 million in 2022, then fell by 2.33% to $63.0 million in 2023, then surged by 49.77% to $94.3 million in 2024, then increased by 20.01% to $113.2 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $113.2 million (Q4 2025), $111.6 million (Q2 2025), and $94.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Brainsway | 900.00 | -68.84 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 113.19 Mn |
| Jun 30, 2025 | 111.56 Mn |
| Dec 31, 2024 | 94.32 Mn |
| Dec 31, 2023 | 62.97 Mn |
| Dec 31, 2022 | 64.48 Mn |
| Dec 31, 2021 | 75.73 Mn |
| Sep 30, 2021 | 74.08 Mn |
| Jun 30, 2021 | 74.49 Mn |
| Mar 31, 2021 | 76.09 Mn |
| Dec 31, 2020 | 34.01 Mn |
| Sep 30, 2020 | 34.38 Mn |
| Dec 31, 2019 | 38.74 Mn |
| Sep 30, 2019 | 38.74 Mn |
| Dec 31, 2018 | 23.60 Mn |